Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

NCT04772001 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Neoplasms
Chemoradiotherapy
Angiogenesis

Interventions

DRUG: Hydrochloride anlotinib
DRUG: cis Platinum/carboplatin
RADIATION: External beam radiotherapy and brachytherapy

Sponsor

Zhongnan Hospital